323 results
8-K
EX-10.1
FOLD
Amicus Therapeutics Inc
21 Dec 10
Departure of Directors or Certain Officers
12:00am
of active duty service shall not result in any reduction in compensation or benefits payable to Employee under Section 3 of this Amended Agreement … additional remuneration therefor.
Section 3.Compensation and Benefits.
3.1Base Salary. During the Employment Term (as defined in Section 5 hereof
8-K
EX-10.3
FOLD
Amicus Therapeutics Inc
25 Apr 14
Departure of Directors or Certain Officers
12:00am
3. Compensation and Benefits .
3.1 Base Salary . During the Employment Term (as defined in Section 4 hereof), the Company shall pay Employee a salary … the 15th day of the third month following the end of the calendar year in which the Bonus was earned.
3.3 Benefits
(a) Benefit Plans . During
S-1
EX-10.8
FOLD
Amicus Therapeutics Inc
17 May 06
IPO registration
12:00am
or benefits
payable to Employee under Section 3 of this Amended Agreement. At all times
during which Employee remains President and Chief Executive … , as an officer or
director of any Company affiliate, in each case without additional remuneration
therefor.
SECTION 3. Compensation and Benefits
8-K
EX-10.1
FOLD
Amicus Therapeutics Inc
31 Dec 08
Departure of Directors or Principal Officers
12:00am
in compensation or benefits payable to Employee under Section 3 of this Amended Agreement. At all times during which Employee remains President … and Benefits.
3.1Base Salary. During the Employment Term (as defined in Section 5 hereof), the Company shall pay Employee a salary at the annual rate
8-K
EX-10.1
hm6oww jy
25 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
bagd3p50krzinx
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
8pfsiwbc4z bhyp88c
1 Aug 22
Departure of Directors or Certain Officers
5:10pm
8-K
EX-10.2
n2vgy
25 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
nu0x9 g3i6
18 Apr 11
Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
12:00am
8-K
xl97si hr
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
vqumr8skj lovbumb
30 Jun 11
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
12:00am